Inserm Transfert, founded in 2000, is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding. It works under a Public service Delegation Agreement (DSP).
number of contracts and licenses*
* For the year 2020
millions of euros invested in Proof of concept
The company supports Inserm research units and researchers in the process undertaken to create value from their work. Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value.
L’Inserm et la mesure de la Préservation de l'emploi de R&D en Santé